Dr. Nagarwala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10 Walnut Ct
Avenel, NJ 08550- Is this information wrong?
Education & Training
Grant Medical CollegeClass of 1999
Clinical Trials
- A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy Start of enrollment: 2001 Nov 01
- Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2004 Mar 01
- CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer Start of enrollment: 2005 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsCost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple...Saad Z. Usmani, James D. Cavenagh, Andrew R. Belch, Cyrille Hulin, Supratik Basu, Darrell White, Ajay K. Nooka, Annette Ervin-Haynes, Wai Yiu, Yasir Nagarwala, Ariel B...> ;Journal of Medical Economics. 2016 Jan 1
- 31 citationsPatterns of total cost and economic consequences of progression for patients with newly diagnosed multiple myelomaSteven R. Arikian, Dejan Milentijevic, Gary Binder, Craig J. Gibson, X. Henry Hu, Yasir Nagarwala, Mohamad A. Hussein, Frank A. Corvino, Andy Surinach, Saad Z. Usmani> ;Current Medical Research and Opinion. 2015 Mar 18
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
